{"cik":1818674,"entityName":"SYBLEU INC","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2020-10-28","val":9418000,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2021-01-13","val":10418000,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}}},"us-gaap":{"AccruedLiabilitiesCurrent":{"label":"Accrued Liabilities, Current","description":"Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-06-30","val":0,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":0,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":150,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":302,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2020-06-30","val":145,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":145,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":149,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":100049,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":{"label":"Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount","description":"Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.","units":{"shares":[{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-06-30","val":8550,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":8550,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":155,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":58094,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-06-30","val":8550,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":8550,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":155,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":58094,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"Cash":{"label":"Cash","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-06-30","val":5050,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":5050,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":155,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":58094,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-06-30","val":5050,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":5050,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":155,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":58094,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"CashAndCashEquivalentsPeriodIncreaseDecrease":{"label":"Cash and Cash Equivalents, Period Increase (Decrease)","description":"Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":-4895,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"}]}},"CommonStockOtherSharesOutstanding":{"label":"Common Stock, Other Shares, Outstanding","description":"Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.","units":{"shares":[{"end":"2020-06-30","val":9353000,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":9353000,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":9418000,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":10418000,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD":[{"end":"2020-06-30","val":0.0001,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":0.0001,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":0.0001,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":0.0001,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-06-30","val":100000000,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":100000000,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":100000000,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":100000000,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-06-30","val":9353000,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":9353000,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":9418000,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":10418000,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-06-30","val":935,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":935,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":942,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":1042,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"CostsAndExpenses":{"label":"Costs and Expenses","description":"Total costs of sales and operating expenses for the period.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":21896,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":34463,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"EarningsPerShareBasicAndDiluted":{"label":"Earnings Per Share, Basic and Diluted","description":"The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":0,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":840,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":5268,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":{"label":"Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest","description":"Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":-21896,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":-34463,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"IncomeTaxExpenseBenefit":{"label":"Income Tax Expense (Benefit)","description":"Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":0,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"IncomeTaxesPaidNet":{"label":"Income Taxes Paid, Net","description":"The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"}]}},"IncreaseDecreaseInAccruedLiabilities":{"label":"Increase (Decrease) in Accrued Liabilities","description":"The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":150,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"}]}},"IncreaseDecreaseInPrepaidExpense":{"label":"Increase (Decrease) in Prepaid Expense","description":"The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":-3500,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"}]}},"InformationTechnologyAndDataProcessing":{"label":"Information Technology and Data Processing","description":"The amount of expenses incurred in the period for information technology and data processing products and services.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":6100,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":6500,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"InterestPaidNet":{"label":"Interest Paid, Excluding Capitalized Interest, Operating Activities","description":"Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"}]}},"LegalFees":{"label":"Legal Fees","description":"The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":500,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"}]}},"Liabilities":{"label":"Liabilities","description":"Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.","units":{"USD":[{"end":"2020-06-30","val":11329,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":11329,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":24819,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":17221,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-06-30","val":8550,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":8550,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":155,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":58094,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-06-30","val":11329,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":11329,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":24819,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":17221,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"LiabilityForUncertainTaxPositionsCurrent":{"label":"Liability for Uncertainty in Income Taxes, Current","description":"Amount recognized for uncertainty in income taxes classified as current.","units":{"USD":[{"end":"2020-09-30","val":0,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":0,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":13340,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":-18235,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":-21896,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":-34463,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"NotesPayableRelatedPartiesClassifiedCurrent":{"label":"Notes Payable, Related Parties, Current","description":"The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-06-30","val":11329,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":11329,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":24669,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":16919,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"NotesPayableRelatedPartiesNoncurrent":{"label":"Notes Payable, Related Parties, Noncurrent","description":"The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).","units":{"USD":[{"end":"2020-09-30","val":25819,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":16919,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":-21896,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":-34463,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"OtherExpenses":{"label":"Other Expenses","description":"Amount of expense classified as other.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":3500,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":10100,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"OtherGeneralAndAdministrativeExpense":{"label":"Other General and Administrative Expense","description":"Amount of general and administrative expense classified as other.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":125,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":768,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"PrepaidExpenseCurrent":{"label":"Prepaid Expense, Current","description":"Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-06-30","val":3500,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":3500,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":0,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":0,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"ProceedsFromRelatedPartyDebt":{"label":"Proceeds from Related Party Debt","description":"The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":13340,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"}]}},"ProfessionalFees":{"label":"Professional Fees","description":"A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":4011,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":7800,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"ProfitLoss":{"label":"Net Income (Loss), Including Portion Attributable to Noncontrolling Interest","description":"The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.","units":{"USD":[{"start":"2020-06-12","end":"2020-09-30","val":25755,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"start":"2020-07-01","end":"2020-09-30","val":-21896,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":-34463,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":5556,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":9355,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-06-30","val":-3859,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":-3859,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":-25755,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3I"},{"end":"2020-12-31","val":-60218,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"Revenues":{"label":"Revenues","description":"Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":0,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2020-06-30","val":-2779,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q2I"},{"end":"2020-06-30","val":-2779,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-09-30","val":-24664,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q3I"},{"end":"2020-09-30","val":-24664,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"},{"end":"2020-12-31","val":40873,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4I"}]}},"StockIssuedDuringPeriodValueIssuedForServices":{"label":"Stock Issued During Period, Value, Issued for Services","description":"Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":11,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q3"},{"start":"2020-07-01","end":"2020-09-30","val":11,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03"}]}},"StockIssuedDuringPeriodValueNewIssues":{"label":"Stock Issued During Period, Value, New Issues","description":"Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.","units":{"USD":[{"start":"2020-10-01","end":"2020-12-31","val":100000,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2020-07-01","end":"2020-09-30","val":9515780,"accn":"0001607062-20-000313","fy":2021,"fp":"Q1","form":"10-Q","filed":"2020-11-03","frame":"CY2020Q3"},{"start":"2020-10-01","end":"2020-12-31","val":9989429,"accn":"0001607062-21-000009","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-01-15","frame":"CY2020Q4"}]}}}}}